| Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR (NCT05054400) | M.D. Anderson Cancer Center | 2020-02-05 |
| Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy (NCT03952598) | National Cancer Institute (NCI) | 2019-10-16 |
| Nivolumab for Recurrent or Progressive IDH Mutant Gliomas (NCT03557359) | Fabio Iwamoto, MD | 2018-06-12 |
| Chronic Convection Enhanced Delivery of Topotecan (NCT03154996) | Columbia University | 2018-01-18 |
| ZOOMit-fMRI Identifies Motor Functional Cortex (NCT03091270) | Beijing Neurosurgical Institute | 2016-02-01 |
| More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery (NCT01445691) | Constantinos Hadjipanayis | 2015-11-01 |
| Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs (NCT02332889) | University of Louisville | 2015-04-01 |
| C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression (NCT01961934) | Phoenix Molecular Imaging | 2014-05-01 |
| Location-Molecular Integrated Outcomes in 450 Cerebellar Glioma Microsurgical Cases (NCT07342699) | West China Hospital | 2014-01-01 |
| Efficacy of Tranexamic Acid in Brain Tumor Resections (NCT01655927) | Colombian Foundation for Epilepsy and Neurological Disease | 2012-07-01 |
| Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents (NCT01517776) | Martin-Luther-Universität Halle-Wittenberg | 2012-01-01 |
| A Pilot Study of Inpatient Hospice With Procurement of Brain Tumor Tissue on Expiration for Research Purposes (NCT01251913) | National Cancer Institute (NCI) | 2010-11-12 |
| Cellular Immunotherapy Study for Brain Cancer (NCT01144247) | Jonsson Comprehensive Cancer Center | 2010-07-01 |
| 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors (NCT00967577) | Weill Medical College of Cornell University | 2009-07-01 |
| A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 in High Grade Gliomas (NCT00589706) | Drexel University College of Medicine | 1985-01-01 |